Add BrightSurf on Google Email

Murdoch Childrens Research Institute


COVID-19 vaccines are effective against severe cases in children

A Murdoch Children's Research Institute-led review found COVID-19 vaccines are effective against severe cases of the disease in children and adolescents. However, with most children now having caught the SARS-CoV-2 virus and building up a natural immunity, the additional benefit of vaccination in healthy children is minimal. The review...

SourceMurdoch Childrens Research Institute·JournalBMJ Paediatrics Open·TypeLiterature review·DateAug 20, 2023

BCG vaccine does not protect against COVID-19 in healthcare workers

A world-leading international trial has found that the BCG vaccine does not protect healthcare workers against COVID-19, despite boosting 'front-line' immunity in infants and protecting against respiratory infections. The research involved 3988 healthcare workers and showed a higher risk of symptomatic COVID-19 in the BCG group.

SourceMurdoch Childrens Research Institute·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateApr 26, 2023

Researchers uncover how gene that increases risk of genetic heart disease works, paving way for new treatments

A recent study led by Murdoch Children's Research Institute has revealed a new pathway for how genetic mutations impact heart muscle function. The research identifies the gene ALPK3 as a key player in cardiomyopathy, a group of diseases affecting the heart's ability to pump blood, and provides hope for new targeted therapies.

SourceMurdoch Childrens Research Institute·JournalNature Cardiovascular Research·TypeExperimental study·DateMar 1, 2023

Babies born preterm decreased slightly and stillborn rates unchanged during first wave of COVID-19 lockdowns

A large-scale international study found that COVID-19 lockdowns led to a 3-4% reduction in preterm births worldwide, averting nearly 50,000 preterm pregnancies during the first month of lockdown. However, this decrease was limited to high-income countries, including Australia.

SourceMurdoch Childrens Research Institute·JournalNature Human Behaviour·TypeObservational study·DateFeb 27, 2023

World-first guidelines created to help prevent heart complications in children during cancer treatment

The world's first international clinical guidelines have been created to prevent and treat heart complications in children undergoing cancer treatment. The guidelines cover cardiovascular disease assessment, screening, and follow-up for pediatric patients receiving various cancer treatments.

SourceMurdoch Childrens Research Institute·JournalJACC Advances·TypeContent analysis·DateJan 29, 2023

Simple nasal spray significantly reduces snoring and breathing difficulties in children

A simple saline nasal spray was found to be as effective as an anti-inflammatory steroid nasal spray at easing sleep disordered breathing in children. The study showed that the nasal spray cleared symptoms while asleep in about 40% of cases and reduced the need for tonsil removals by half.

SourceMurdoch Childrens Research Institute·JournalJAMA Pediatrics·TypeRandomized controlled/clinical trial·DateJan 17, 2023

Immune cell model paves way for new treatments targeting common infection amongst immunocompromised children

Researchers have successfully engineered human immune cells to model an infection common among immunocompromised people, paving the way for new drug testing and treatments. The immune cell type created played a key role in infection, inflammation, and regeneration, but also served as a natural host for germs.

SourceMurdoch Childrens Research Institute·JournalStem Cell Reports·TypeExperimental study·DateAug 18, 2022

Immune boosting benefits of tuberculosis vaccine seen in infants more than a year after vaccination

A new study has shown that the TB vaccine can produce a long-lasting 'trained immunity response' in infants, lasting more than 14 months after vaccination. The research found that the BCG vaccine's off-target effects on the immune system can lead to reprogramming of genes in a specific blood cell type, known as monocytes.

SourceMurdoch Childrens Research Institute·JournalScience Advances·TypeRandomized controlled/clinical trial·DateAug 5, 2022

Caesarean births not linked to increased risk of food allergy during infancy

A recent study published by the Murdoch Children's Research Institute found no significant association between caesarean birth and the development of food allergies in infants. The research involved over 2,000 infants and suggested that babies born via caesarean delivery are not at a higher risk of developing food allergies.

SourceMurdoch Childrens Research Institute·JournalJournal of Allergy and Clinical Immunology: In Practice·TypeObservational study·DateMay 18, 2022

Most children living in out of home care don’t access health services

A new study found that most children living in out-of-home care don't access health services within nationally required timeframes, highlighting a significant gap in the system. The research revealed that only one in 130 had attended all recommended health services within 12 months of entering out-of-home care.

SourceMurdoch Childrens Research Institute·JournalChildren and Youth Services Review·TypeObservational study·DateMar 3, 2022

Serious allergic reactions to food among children stabilize since guideline changes

A new study found that serious allergic reactions to food among children have flattened since changes to Australian infant feeding guidelines. The research showed a slowing rate of increase in hospital admissions for food anaphylaxis among young children and teenagers, but overall rates remain high. Experts emphasize the need for effec...

SourceMurdoch Childrens Research Institute·JournalJournal of Allergy and Clinical Immunology·DateFeb 23, 2022

Calls for resilience training, more extra-curricular activities in schools to help prevent mental health disorders

A new study by Murdoch Children's Research Institute calls for increased support for student mental health, including training for educators and co-locating mental health clinicians. The researchers believe schools can play a crucial role in identifying at-risk children and providing prevention and early intervention strategies.

SourceMurdoch Childrens Research Institute·JournalPLOS ONE·TypeSurvey·DateFeb 6, 2022

Researchers discover two treatments that induce peanut allergy remission in children

Two new treatments have been found to induce peanut allergy remission in children, with about half achieving remission and experiencing significant improvements in quality of life. The combination treatment and oral immunotherapy alone were both highly effective, providing substantial benefits for children's health and well-being.

SourceMurdoch Childrens Research Institute·JournalThe Lancet Child & Adolescent Health·TypeRandomized controlled/clinical trial·DateFeb 4, 2022

Dose-finding trial paves way for new rotavirus vaccine to prevent a deadly diarrheal disease from birth

A phase 2 clinical trial found that the Australian-developed neonatal rotavirus vaccine RV3-BB was safe and produced a robust immune response in African babies. The reduced dose of the vaccine generated an equivalent immune response as the highest dose, offering opportunities to reduce vaccine manufacturing costs.

SourceMurdoch Childrens Research Institute·JournalThe Lancet Infectious Diseases·TypeRandomized controlled/clinical trial·DateFeb 3, 2022

New test to screen newborns for rare genetic disorders paves the way for earlier diagnosis and treatment

A new test has been developed to screen for three rare genetic disorders - Prader Willi, Angelman, and Dup15q syndromes - in newborns. The test uses Methylation Specific-Quantitative Melt Analysis (MS-QMA) and showed high accuracy in distinguishing between those with the disorders and those without.

SourceMurdoch Childrens Research Institute·JournalJAMA·TypeRandomized controlled/clinical trial·DateJan 24, 2022

Penicillin significantly reduces rheumatic heart disease progression in children

A new study found that regular antibiotic treatment with penicillin significantly reduced the risk of underlying rheumatic heart disease progression in children and adolescents. Early screening was critical in preventing serious disease progression and death in young children.

SourceMurdoch Childrens Research Institute·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateNov 13, 2021

Most children with cancer have mild COVID-19 and make full recovery

A new study published in the European Journal of Cancer found that most children with cancer have mild COVID-19 disease and make a full recovery. However, patients with underlying health conditions, severe infections, and low white blood cell counts were significantly more likely to experience severe disease. The research involved 131 ...

SourceMurdoch Childrens Research Institute·JournalEuropean Journal of Cancer·TypeObservational study·DateNov 9, 2021

Cell-based influenza vaccine provides protection against the flu in children

A cell-based quadrivalent influenza vaccine has effectively provided protection against the flu in children and adolescents. The study found that the vaccine produced a sufficient immune response in children aged two to 18 years, with an overall vaccine efficacy of 54.6 per cent.

SourceMurdoch Childrens Research Institute·JournalNew England Journal of Medicine·TypeRandomized controlled/clinical trial·DateOct 14, 2021

Test screening for leading infectious cause of hearing loss in babies feasible and well-received

A new saliva test for congenital cytomegalovirus (cCMV) has been shown to be feasible and well-received by parents, with high uptake and accuracy rates. The test could lead to early diagnosis and treatment of cCMV-related hearing loss and neurodevelopmental disorders.

SourceMurdoch Childrens Research Institute·JournalJournal of Paediatrics and Child Health·TypeObservational study·DateSep 15, 2021

Cost of raising a child with rare genetic disorder significant but could be reduced by earlier diagnosis

A new study found that the economic burden of caring for children with rare genetic disorders such as Fragile X syndrome and Chromosome 15 imprinting disorders is significant. Earlier diagnosis and targeted interventions could reduce yearly costs by up to $734, depending on the child's intellectual functioning.

SourceMurdoch Childrens Research Institute·JournalJournal of Autism and Developmental Disorders·TypeObservational study·DateAug 26, 2021